早期肺癌临床试验中时间依赖性放疗诱导淋巴细胞耗竭的预测模型
本研究建立基于Python的模型,模拟血液与富淋巴器官间淋巴细胞循环动力学,预测早期肺癌立体定向体部放疗(SBRT)后6个月内时间依赖性放疗诱导淋巴细胞耗竭(RILD)及外周绝对淋巴细胞计数(ALC)轨迹。模型在64例回顾队列优化、51例独立试验队列(NCT04273893)测试,预测与实测ALC平均差0.28×10^9细胞/L,83%预测值在实测值0.5×10^9细胞/L内,预测最低ALC百分比与总生存和无事件生存显著相关。
要点
- 模型可基于DICOM放疗数据预测SBRT后6个月内ALC轨迹。
- 独立测试队列中83%预测值在实测值0.5×10^9细胞/L内。
- 淋巴系统照射是最低ALC出现时间和最低值的主要驱动因素。
核心结论
- 模型能预测早期肺癌SBRT患者治疗后6个月内时间依赖性ALC轨迹,支持从治疗计划估算个体化RILD。
研究设计与样本
- 基于Python的模型以DICOM格式放疗数据为输入,模拟血液与富淋巴隔室间淋巴细胞循环实时耦合动力学。
- 模型在64例回顾性队列中优化,在NCT04273893临床试验的51例独立队列中测试。
主要发现
- 独立测试队列中预测与实测ALC平均[SD]绝对差为0.28[0.23]×10^9细胞/L,83%预测值在实测值0.5×10^9细胞/L内。
- 模型成功捕捉富血和富免疫器官照射对RILD的贡献。
- 模型对血液以外器官隔室淋巴细胞数量的纵向预测表明,淋巴系统照射是最低ALC出现时间和最低ALC的主要驱动因素。
- 预测最低ALC百分比与总生存和无事件生存均显著相关。
关键数值与推荐
- 独立测试队列中预测与实测ALC平均[SD]绝对差为0.28[0.23]×10^9细胞/L,83%预测值在实测值0.5×10^9细胞/L内。
- 采用Spearman秩相关和点二列相关分析剂量学参数和患者特征对RILD的影响及模型解释能力。
- 采用Kaplan-Meier分析伴log-rank检验及单变量Cox比例风险模型评估预测最低ALC百分比与总生存/无事件生存的关联。
临床怎么用
- 可利用治疗计划估算个体化RILD,支持在保留标准SBRT的同时通过治疗个体化减轻免疫毒性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Radiation-induced lymphocyte depletion (RILD) varies substantially among patients, and the extent to which different factors contribute to RILD remains incompletely understood. We present a model to predict time-dependent RILD for patients with early-stage lung cancer treated with stereotactic body radiation therapy (SBRT) by simulating the lymphocyte circulation dynamics in blood and lymph-rich organs. METHODS AND MATERIALS: The Python-based model took radiation therapy data in digital imaging and communications in medicine (DICOM) format from patients as input and simulated the real-time coupled dynamics of lymphocyte circulation between blood and lymph-rich compartments to estimate RILD and predict longitudinal peripheral absolute lymphocyte count (ALC) trajectories up to 6-month post-treatment. The model was optimized using a retrospective cohort of 64 patients and tested on an independent cohort of 51 patients from clinical trial NCT04273893. Spearman's rank correlation and point-biserial correlation were used to analyze the impact of dosimetric parameters and patient characteristics on RILD and the model's ability to account for these parameters. Associations between model-predicted nadir ALC percentage and overall survival/event-free survival were assessed using Kaplan-Meier analysis with log-rank tests and univariate Cox proportional hazards models. RESULTS: In the independent test cohort, the mean [SD] absolute ALC difference between prediction and measurement was 0.28[0.23]×109 cell/L, with 83% of predictions within 0.5×109 cell/L of observed values. The model successfully captured the contributions of irradiating blood-rich and immune-rich organs to RILD. The model's ability to make longitudinal predictions of lymphocyte numbers in organ compartments beyond blood indicated that irradiation of the lymphatic system was the primary driver of nadir timing and nadir ALC. Predicted nadir ALC percentage was significantly associated with both overall survival and event-free survival. CONCLUSIONS: The model forecasted time-dependent ALC trajectories for patients with lung cancer undergoing SBRT up to 6 months post-treatment. This approach enables estimation of individualized RILD from treatment plans, supporting treatment personalization to mitigate immune toxicity while preserving standard-of-care SBRT.
引用
- Nguyen C, Chen J, Larner J, et al. Forecasting Time-Dependent Radiation-Induced Lymphocyte Depletion in a Clinical Trial on Early-Stage Lung Cancer. Int J Radiat Oncol Biol Phys. 2026. PMID: 42612832. doi:10.1016/j.ijrobp.2026.08.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。